Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PAF, eosinophils and asthma.

P J Barnes1

  • 1National Heart and Lung Institute, London, UK.

Journal of Lipid Mediators
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Platelet-activating factor (PAF) causes airway inflammation, mimicking asthma. It promotes eosinophil activity, potentially driving the inflammation seen in asthma and airway hyperresponsiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid resistance in asthma.

American journal of respiratory and critical care medicine·1995
Same author

Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.

The Journal of experimental medicine·1995
Same author

Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.

Molecular pharmacology·1995
Same author

Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages.

The American journal of physiology·1995
Same author

Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction.

Thorax·1995
Same journal

Cytosolic PLA2: mRNA levels and potential for transcriptional regulation.

Journal of lipid mediators·1993
Same journal

Phospholipase D-mediated hydrolysis of phosphatidylcholine: role in cell signalling.

Journal of lipid mediators·1993
Same journal

Sphingosine and sphingosine 1-phosphate in cellular proliferation: relationship with protein kinase C and phosphatidic acid.

Journal of lipid mediators·1993
Same journal

Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes.

Journal of lipid mediators·1993
Same journal

PAF-releasing factor in human serum and inflammatory exudate.

Journal of lipid mediators·1993
Same journal

5-Lipoxygenase activity in the human pancreas.

Journal of lipid mediators·1993
See all related articles

Area of Science:

  • Pulmonary immunology
  • Inflammatory mediators

Background:

  • Platelet-activating factor (PAF) is implicated in airway inflammation.
  • PAF's effects resemble the pathological processes observed in asthma.

Purpose of the Study:

  • To investigate the role of PAF in airway inflammation and asthma pathophysiology.
  • To explore PAF's influence on eosinophil accumulation and activation in the airways.

Main Methods:

  • Review of existing literature on PAF and asthma.
  • Analysis of PAF's inflammatory mechanisms in the respiratory system.

Main Results:

  • PAF exhibits significant inflammatory effects within the airways.
  • PAF acts as a potent stimulant for eosinophil accumulation and activation.

Related Experiment Videos

  • PAF is strongly associated with eosinophilic inflammation characteristic of asthma.

    • Conclusions:

    • PAF plays a crucial role in airway inflammation, closely mirroring asthma's pathophysiology.
    • PAF's ability to drive eosinophil responses suggests its involvement in asthma-related inflammation and airway hyperresponsiveness.